News
-
Flow chemistry for efficient and safe synthesis of APIs
Today, a confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market
-
Angelini Fine Chemicals is expanding its catalytical hydrogenation capacity with two reactors
Angelini Fine Chemicals, Business Unit of Angelini Pharma, specialized in the production of active pharmaceutical ingredients, has installed two reactors for catalytic hydrogenation in the Aprilia (LT) plant...
-
Angelini Fine Chemicals is a business unit of Angelini Pharma, specialized in the third party production of active pharmaceutical ingredients
Angelini Fine Chemicals invested in Flow Chemistry.
-
Panel discussion on Supply Chain
COVID-19: A catalyst for the global pharma supply chain transformation
-
Panel discussion on Flow Chemistry
Flow chemistry as synthetic tool to access novel chemical space for pharmaceutical industry
-
Angelini Fine Chemicals increases the production of High Potent Active Pharmaceutical Ingredients
HPAPIs are becoming increasingly central to the world of the pharmaceutical industry.
-
Angelini Fine Chemicals developed a new area to increase the production of HPAPI
Angelini Fine Chemicas increased its focus on the production of high-potent active pharmaceutical ingredients (HPAPls).
-
Angelini Pharma broadens its HPAPI CDMO capabilities
Responding to the rising number of custom HPAPIs demand, Angelini Fine Chemicals is expanding its HPAPI capacity at its Aprilia,Italy plant site...
-
Angelini Fine Chemicals COVID-19 - Customer Letter
Angelini has encouraged smart working to manage the emergency and contribute to the public safety.
-
Angelini Fine Chemicals COVID-19
Angelini fine chemicals in line with the Angelini Pharma Group support the actions undertaken by the Government which are fully in line with our corporate values, the ethics...
